American Journal of Hematology · 2004 · 16 citations · 13 references
MedicineHematologyOncologyEndocrine OncologyHematologic OncologyMedical OncologyHematologic MalignanciesHematologic Malignancy PharmacotherapyHematologic Malignancy TherapyLymphoid NeoplasmsLymphoid TumorsAndrogen SensitivityC1 Esterase Inhibitor DeficiencyC1 InhibitorSplenic LymphomaSplenic Marginal Zone LymphomaSymptomatic PharmacotherapySymptomatic Presentation
A patient with splenic marginal zone lymphoma presented with severe, symptomatic acquired angioedema. Unlike previously reported cases, his serum levels of complement and C1 inhibitor (C1-INH) were not decreased. Nonetheless, he responded clinically to treatment with an attenuated androgen and, after therapeutic splenectomy, has been maintained asymptomatic without androgen therapy for 5 years. Thus stimulation of C1-INH synthesis may overcome paraneoplastic angioedema in patients with lymphoproliferative disorders despite the absence of typical evidence for a quantitative or qualitative defect in C1-INH. Androgens should not be withheld despite a normal level of C1-INH and complement in symptomatic patients.
13
Hereditary and Acquired C1-Inhibitor Deficiency
A Agostoni, Marco Cicardi · Medicine · 1992 · 612 citations
Life Sciences, Genetics, Immunology +13
Hereditary angioedema with normal C1-inhibitor activity in women
Konrad Bork, Sven-Erik Barnstedt, Petra Koch et al. · The Lancet · 2000 · 552 citations
Acquired inhibitor deficiency in lymphosarcoma
Joshua Caldwell, Shaun Ruddy, P H Schur et al. · Clinical Immunology and Immunopathology · 1972 · 215 citations
Medicine, Immunology, Oncology +12